Laboratory of Clinical Science and Biomedicine, Graduate School of Pharmaceutical Sciences, Osaka University, Suita City, Osaka, Japan.
Project of Clinical Pharmacology and Therapeutics, Graduate School of Pharmaceutical Sciences, Osaka University, Suita City, Osaka, Japan.
Pharmacol Res Perspect. 2020 Apr;8(2):e00590. doi: 10.1002/prp2.590.
In cardiovascular diseases, cardiac fibroblasts (CFs) participate in the myocardial inflammation by producing pro-inflammatory cytokines, worsening the prognosis. β2-adrenergic receptor (AR) and β3AR are expressed in CFs, and β-adrenergic stimulation promotes CFs to produce pro-inflammatory cytokines. However, the mechanism of the expression of pro-inflammatory cytokines in response to β-adrenergic stimulation remains to be fully elucidated.
CFs were isolated from adult wild-type or AT-rich interactive domain-containing protein 5A (Arid5a) knockout mice. The expression of mRNA was measured by real-time RT-PCR. Interleukin (IL)-6 protein was measured by ELISA. The activity of nuclear factor-κB (NF-κB) and cyclic AMP (cAMP) response element binding protein (CREB) was assessed by ELISA-like assay or Western blotting.
The β-adrenergic stimulation remarkably induced IL-6 mRNA and protein through β2AR in CFs. The activation of adenylate cyclase and the enhancement of intracellular cAMP resulted in the upregulation of IL-6 mRNA expression. The induction of IL-6 transcript by β2AR signaling was independent of NF-κB. Concomitant with IL-6, the expression of Arid5a, an IL-6 mRNA stabilizing factor, was enhanced by β2-adrenergic stimulation and by cAMP increase. Importantly, β2AR signaling-mediated IL-6 induction was suppressed in Arid5a knockout CFs. Finally, β2AR stimulation phosphorylated CREB via PKA pathway, and the activation of CREB was essential for the induction of Arid5a and IL-6 mRNA.
β2-adrenergic stimulation post-transcriptionally upregulates the expression of IL-6 by the induction of Arid5a through cAMP/PKA/CREB pathway in adult CFs. β2AR/Arid5a/IL-6 axis could be a therapeutic target against cardiac inflammation.
在心血管疾病中,心肌成纤维细胞(CFs)通过产生促炎细胞因子参与心肌炎症,从而使预后恶化。β2-肾上腺素能受体(AR)和β3AR 在 CFs 中表达,β-肾上腺素能刺激促进 CFs 产生促炎细胞因子。然而,β-肾上腺素能刺激引起促炎细胞因子表达的机制仍有待充分阐明。
从成年野生型或富含 AT 的相互作用域蛋白 5A(Arid5a)敲除小鼠中分离 CFs。通过实时 RT-PCR 测量 mRNA 的表达。通过 ELISA 测量白细胞介素(IL)-6 蛋白。通过 ELISA 样测定或 Western blot 测定核因子-κB(NF-κB)和环磷酸腺苷(cAMP)反应元件结合蛋白(CREB)的活性。
β-肾上腺素能刺激通过 CFs 中的β2AR 显著诱导 IL-6 mRNA 和蛋白。腺嘌呤环化酶的激活和细胞内 cAMP 的增加导致 IL-6 mRNA 表达上调。β2AR 信号转导诱导 IL-6 转录不依赖于 NF-κB。伴随着 IL-6,IL-6 mRNA 稳定因子 Arid5a 的表达被β2-肾上腺素能刺激和 cAMP 增加增强。重要的是,β2AR 信号介导的 IL-6 诱导在 Arid5a 敲除 CFs 中受到抑制。最后,β2AR 刺激通过 PKA 途径磷酸化 CREB,并且 CREB 的激活对于诱导 Arid5a 和 IL-6 mRNA 是必需的。
β2-肾上腺素能刺激通过 cAMP/PKA/CREB 途径在后转录水平上上调成年 CFs 中 IL-6 的表达,通过诱导 Arid5a。β2AR/Arid5a/IL-6 轴可能是针对心脏炎症的治疗靶点。